Hanover Insurance grants CEO Roche 120 stock units
The RSUs relate to dividend equivalent rights on earlier awards and vest on the third anniversary of the original grant date.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
The Hanover Insurance Group, Inc. reported that its President and CEO, John C. Roche, received a grant of 120 restricted stock units on September 25, 2026. The grant was made under the company’s 2022 Long-Term Incentive Plan in connection with dividend equivalent rights on previously granted RSUs; these RSUs vest on the third anniversary of the original underlying RSUs’ grant date. Roche’s reported direct common-stock holdings after the grant were 141,253 shares, excluding 14,454 shares held by his spouse.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1, F2 | 120.052 | $0.00 | $0.00 |
Footnotes (2)
- F1. Grant of restricted stock units ("RSUs") under the Issuer's 2022 Long-Term Incentive Plan ("2022 LTIP") in connection with the accrual of dividend equivalent rights associated with RSUs previously granted under the Issuer's 2022 LTIP. Such RSUs vest on the third anniversary of the date of grant of the original underlying RSUs.
- F2. Does not include 14,454 shares held by the Reporting Person's spouse.
Key Figures
Key Terms
restricted stock units financial
dividend equivalent rights financial
2022 Long-Term Incentive Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many RSUs did THG CEO John C. Roche receive?
When do John C. Roche’s THG RSUs vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.